Zusammenfassung
Mehr als die Hälfte aller Lungenkarzinome sind im Oberlappen lokalisiert. Die anatomische Nähe zum Lungenhilus birgt das Risiko der Tumorinfiltration von zentralen Strukturen des Bronchial- und Gefäßbaumes. Bei der Resektion der zentralen Tumoren konkurrieren die Pneumonektomie und Manschettenresektion am Bronchial- und Gefäßbaum der Lunge. Die vorliegende Übersichtsarbeit befasst sich mit der Frage, ob die Pneumonektomie eine Alternative zur Manschettenresektion beim Lungenkarzinom darstellt. Bei gleichwertiger onkologischer Radikalität für beide Operationsverfahren sind die Lokalrezidivraten niedriger nach Manschettenresektionen. Eine primäre Pneumonektomie bringt auch im fortgeschrittenen Lymphknotenstatus keinen Vorteil. Erweiterte Lymphknotendissektionen sind für die Manschettenchirurgie keine Kontraindikation. Mortalitäts- und Morbiditätsraten sind signifikant niedriger bei der Sleeve-Resektion. Manschettenresektionen sind mit einem besseren Überleben und einer besseren Lebensqualität vergesellschaftet, selbst im höheren Lebensalter.
Abstract
Lung cancer is localized in the upper lobes in more than half of the cases. The risk of tumor infiltration of centrally located structures, such as bronchi and vessels are enhanced due to the anatomic topography. Pneumonectomy competes with sleeve resection for the surgical resection of centrally located tumors. The present review deals with the question if pneumonectomy should be considered as an alternative to sleeve resection for the treatment of lung cancer. Primary pneumonectomy does not provide any advantage even in advanced nodal disease. Extended lymph node dissection is not a contraindication for sleeve resections. Local recurrence rate is lower after sleeve resections despite the same radicality for both surgical treatment options. Mortality and morbidity rates are significantly lower for sleeve resections. Sleeve resections are associated with prolonged survival and better quality of life even in elderly patients.
Literatur
Balduyck B, Hendriks J, Lauwers P, Van Schil P (2008) Quality of life after lung cancer surgery: a prospective pilot study comparing bronchial sleeve lobectomy with pneumonectomy. J Thorac Oncol 3(6):604–608
Bölükbas S, Eberlein M, Schirren J (2011) Pneumonectomy vs. sleeve resection for non-small cell lung carcinoma in the elderly: analysis of short-term and long-term results. Thorac Cardiov Surg 59:142–147
Bölükbas S, Eberlein MH, Schirren J (2010) Role of mediastinal lymph node dissection in non-small cell lung cancer. Front Radiat Ther Oncol 42:78–86
Byers TE, Vena JE, Rzepka TF (1984) Predilection of lung cancer for the upper lobes: an epidemiologic inquiry. J Natl Cancer Inst 72(6):1271–1275
Ferguson MK, Lehman AG (2003) Sleeve lobectomy or pneumonectomy: optimal management strategy using decision analysis techniques. Ann Thorac Surg 76:1782–1788
Keller SM, Adak S, Wagner H, Johnson DH (2000) Mediastinal lymph node dissection improves survival in patients with stages II and IIIa non-small cell lung cancer. Eastern Cooperative Oncology Group. Ann Thorac Surg 70(2):358–365
Ma Z, Dong A, Fan J, Cheng H (2007) Does sleeve lobectomy concomitant with or without pulmonary artery reconstruction (double sleeve) have favorable results for non-small cell lung cancer compared with pneumonectomy? A Metaanalysis. Eur J Cardiothorac Surg 32:20–28
Melloul E, Egger B, Krueger T et al (2008) Mortality, complications and loss of pulmonary function after pneumonectomy versus sleeve lobectomy in patients younger and older than 70 years. Interact Cardiovasc Thorac Surg 7:986–989
Okada M, Yamagishi H, Satake S et al (2000) Survival related to lymph node involvement in lung cancer after sleeve lobectomy compared with pneumonectomy. J Thorac Cardiovasc Surg 119:814–819
Page R, Keogh B, Kinsman R (2008) National Thoracic Surgery Activity and Outcome Report 2008 of the Society for Cardio-Thoracic Surgery in Great Britain and Ireland
Pagni S, Federico JA, Ponn RB (1997) Pulmonary resection for lung cancer in octogenarians. Ann Thorac Surg 63:785–789
Riquet M, Arame A (2011) Editorial comment: sleeve lobectomy: time for setting the record straight. Eur J Cardiothorac Surg 40:1163–1164
Schirren J, Bergmann T, Beqiri S et al (2006) Lymphatic spread in resectable lung cancer: can we trust in a sentinel lymph node? Thorac Cardiovasc Surg 54(6):373–380
Schirren J, Bolukbas S, Bergmann T et al (2009) Prospective study on perioperative risks and functional results in bronchial and bronchovascular sleeve resections. Thorac Cardiovasc Surg 57(1):35–41
Schirren J, Kudelin N, Fischer A et al (2011) The role of sleeve resections in advanced nodal disease. Eur J Cardiothorac Surg 40(5):1157–1163
Schirren J, Richter W, Schneider P, Vogt-Moykopf I (1996) Principles and results of systematic lymph node dissection in surgically treated bronchial carcinoma. Chirurg 67(9):869–876
Spiguel L, Ferguson K (2007) Sleeve lobectomy versus pneumonectomy for lung cancer in patients with good pulmonary function. In: Ferguson MK (Hrsg) Difficult decisions in thoracic surgery. Springer, London, S 103–109
Wu YL, Huang ZF, Wang SY et al (2002) A randomized trial of systematic nodal dissection inresectable non-small cell lung cancer. Lung Cancer 36:1–6
Zhong W, Yang X, Bai J et al (2008) Complete mediastinal lymphadenectomy: the core component of the multidisciplinary therapy in resectable non-small cell lung cancer. Eur J Cardiothorac Surg 34:187–195
Interessenkonflikt
Der korrespondierende Autor gibt für sich und seine Koautoren an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Schirren, J., Schirren, M., Passalacqua, M. et al. Pneumonektomie. Chirurg 84, 474–478 (2013). https://doi.org/10.1007/s00104-012-2430-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00104-012-2430-7